Remove Contamination Remove DNA Remove Life Science Remove Packaging
article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination? Why are those important?

article thumbnail

Guide to using AAV vectors in gene therapy

Drug Discovery World

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. Questions were fielded from the audience, which included: What analysis will be performed to evaluate host or other DNA contamination?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

The established method for this process is a triple transfection using three different DNA plasmids. Two-Plasmid Packaging System for Recombinant Adeno-Associated Virus. Cytiva and the Drop logo are trademarks of Life Sciences IP Holdings Corp. link] [2] Tang Q, et al. Biores Open Access. 2020 Oct 16;9(1):219-228.

Genome 244
article thumbnail

COVID-19 Pandemic Coverage

XTalks

trillion) agreement reached in late July between leaders of the 27 countries in the European Union, a truly historic stimulus package designed to rescue flailing economies from COVID-19. The package is made up of a €390 billion fund in grants and a €360 billion in low interest loans. And stimulus packages continue.